Elequin Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25
| Closed | -$1.64K | – | 335 |
|
|
2024
Q4 | $1.64K | Sell |
25
-4
| -14% | -$263 | ﹤0.01% | 432 |
|
|
2024
Q3 | $2.04K | Buy |
+29
| New | +$2.04K | ﹤0.01% | 318 |
|
|
2024
Q2 | – | Sell |
-42
| Closed | -$3.67K | – | 211 |
|
|
2024
Q1 | $3.67K | Buy |
+42
| New | +$3.67K | ﹤0.01% | 166 |
|
|
2023
Q3 | – | Sell |
-99
| Closed | -$8.58K | – | 424 |
|
|
2023
Q2 | $8.58K | Buy |
+99
| New | +$8.58K | ﹤0.01% | 318 |
|
|
2022
Q4 | – | Sell |
-87
| Closed | -$7K | – | 634 |
|
|
2022
Q3 | $7K | Sell |
87
-152
| -64% | -$12.2K | ﹤0.01% | 296 |
|
|
2022
Q2 | $20K | Buy |
239
+50
| +26% | +$4.18K | ﹤0.01% | 192 |
|
|
2022
Q1 | $15K | Buy |
+189
| New | +$15K | ﹤0.01% | 144 |
|